Major histocompatibility complex haplotypes and complement C4 alleles in systemic lupus erythematosus. Results of a...

Area of Science:

• Immunogenetics
• Rheumatology
• Human Genetics

Background:

• Systemic lupus erythematosus (SLE) is a complex autoimmune disease with a strong genetic component.
• Human Leukocyte Antigen (HLA) and complement component 4 (C4) genes are known susceptibility factors for SLE.
• Identifying specific genetic risk factors is crucial for understanding SLE pathogenesis.

Purpose of the Study:

• To investigate the association between specific MHC haplotypes and SLE in a Central European cohort.
• To determine the role of C4 gene deletions and alleles in SLE susceptibility.
• To identify independent genetic risk factors for SLE.

Main Methods:

• Multicenter study analyzing HLA-B, HLA-DR, and C4 phenotypes in over 300 SLE patients.
• MHC haplotype determination using family segregation analysis in 174 SLE patients.
• C4 gene deletion analysis via TaqI restriction fragment length polymorphism in 155 SLE patients.
• Haplotype Frequency Difference (HFD) method utilized for confirmation.

Main Results:

• Two specific MHC haplotypes, B8-C4AQ0-C4B1-DR3 and B7-C4A3-C4B1-DR2, were identified as significant risk factors for SLE.
• HLA-DR2 showed increased frequency in SLE patients independently of the identified risk haplotypes.
• C4A gene deletions, but not C4AQ0 alleles or C4B variations, were significantly increased in SLE patients.
• Risk appears to be conferred by single allele effects rather than homozygosity or heterozygosity for specific haplotypes or C4 deletions.

Conclusions:

• Two distinct MHC-linked susceptibility factors for Caucasian SLE patients are identified: B7-DR2 and B8-DR3 haplotypes.
• The study suggests that C4Q0 alleles are not the primary determinants of SLE susceptibility.
• These findings contribute to a better understanding of the genetic architecture of SLE.